Cerbios’ HPAI manufacturing facility P5 meets control performance within SafeBridge’s® Category 4 17 December 2010
mondoBIOTECH holding AG (SIX:RARE): Presenting at the Biotech in Europe Investor Forum in Zurich 23 September 2010
APR Applied Pharma Research (“APR”) and Labtec GmbH (“Labtec”) announce the successful completion of the pivotal clinical study 15 September 2010
mondoBIOTECH holding AG (SIX:RARE): United States FDA grants mondoBIOTECH’s Medicinal Product Candidate DasKloster0210 the Orphan Drug Designation for the treatment of Chronic Beryllium Disease 14 September 2010
Nautilus Neurosciences and APR Applied Pharma Research s.a. Announce Extension of Patent Protection for CAMBIA™ (diclofenac potassium for oral solution) through 2026 8 September 2010
Linkedin